Chemical & Engineering News: Synthetic biology could enable bioweapons development

by bizlift | Jun 19, 2018 | Portfolio Media Coverage, Twist Press Coverage

SynBioBeta: Targeted Sequencing Changes the NGS Game

by bizlift | Jun 18, 2018 | Portfolio Media Coverage, Twist Press Coverage

BlackThorn Therapeutics Initiates Phase 1 Study of BTRX-335140, an Investigational Kappa Opioid Receptor (KOR) Antagonist

by bizlift | Jun 6, 2018 | BlackThorn Press Coverage, Portfolio Media Coverage

SynBioBeta: Why the future will be written in DNA: An interview with Twist Bioscience’s Bill Peck

by bizlift | May 15, 2018 | Portfolio Media Coverage, Twist Press Coverage

Scientific American: Scientists Downsize Bold Plan to Make Human Genome from Scratch

by bizlift | May 1, 2018 | Portfolio Media Coverage, Twist Press Coverage

Retina Today: In Pursuit of an Earlier Diagnosis

by bizlift | May 1, 2018 | Portfolio Media Coverage, Verana Health Press Coverage